3648 results for «99»
3648 results
Innovations in TAVI: TAVI 2.0
21 May 2026 – From EuroPCR 2026
This session presents cutting-edge advancements in transcatheter aortic valve implantation (TAVI), highlighting the TAVI 2.0 era. It encompasses innovative techniques such as percutaneous and non-fluoroscopic TAVR guided by transthoracic echocardiography (TTE), novel alternative access via the left subscapular approach, and patient-tailored commissural alignment assessed through CT...
Challenging procedures for bifurcation lesions
22 May 2026 – From EuroPCR 2026
Explore a series of challenging cases in coronary bifurcation interventions, highlighting complex decision-making scenarios, pharmaco-invasive strategies guided by IVUS, and tailored techniques for reintervention. Emphasis is placed on imaging-guided PCI and simplifying complex double bifurcation and long lesion treatments to optimize patient outcomes.
Beyond stent: use of DCB in CTO
22 May 2026 – From EuroPCR 2026
This session focuses on the innovative use of drug-coated balloons (DCB) in chronic total occlusion (CTO) interventions. It reviews combined plaque modification techniques, complex multivessel PCI cases involving CTOs, and strategy considerations such as hybrid therapy versus full metal jacket, emphasizing vessel biology preservation during revascularisation.
New insights into pharmacological treatment for STEMI
21 May 2026 – From EuroPCR 2026
This session presents the latest pharmacological advances in the treatment of ST-segment elevation myocardial infarction (STEMI). It covers safety data on ticagrelor monotherapy post-primary PCI, the impact of P2Y12 inhibitor pretreatment, effects of dapagliflozin on myocardial remodeling, and considerations for bleeding risk and vascular preparation strategies...
Is there a rule for DCB in ACS setting?
22 May 2026 – From EuroPCR 2026
This session examines the application of drug-coated balloons (DCB) in the acute coronary syndrome (ACS) setting, comparing outcomes with drug-eluting stents (DES). It discusses the impact of intraluminal thrombus, real-world registry data on DCB-first strategies in STEMI, and multicentre experiences with DCB use in STEMI and...
Updates in tricuspid TEER
21 May 2026 – From EuroPCR 2026
This session offers comprehensive updates on transcatheter edge-to-edge repair (TEER) for tricuspid valve disease. It reviews meta-analyses on outcomes in patients with cardiac implantable electronic device leads, long-term trial results, echocardiographic and clinical outcomes, right ventricular mechanics, risk scoring, and the impact of renal function and...
Technical decision-making for CTO PCI strategy
22 May 2026 – From EuroPCR 2026
This session focuses on technical decision-making for chronic total occlusion PCI strategy. It presents diverse approaches to right coronary CTOs, complex management involving double rendezvous techniques, subintimal strategies, and innovative single-injection methods, demonstrating the evolving frontiers in CTO intervention.
Shock: enhancing our pathways of care
21 May 2026 – From EuroPCR 2026
This session explores advancements in the management pathways for patients experiencing cardiogenic shock, particularly those complicating STEMI. It discusses patient characteristics, timing of PCI procedures, updated SCAI shock staging, representation in clinical trials, and angiographic findings in shockable out-of-hospital cardiac arrest cases, aiming to enhance clinical...